510 pages •
By Roots Analysis Private Ltd.
• May 2017
THIS ALLIANCE WAS FORMED ON A PRIOR AGREEMENT BETWEEN WUXI BIOLOGICS AND MEDIMMUNE ON THE DEVELOPMENT AND COMMERCIALIZATION OF MEDI##, A NOVEL BIOLOGIC DEVELOPED FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES.
" Recent publications and presentations continue to illustrate how we might be able to extend the treatment window for stroke patients out to ## hours with MultiStem, beyond the narrow window for treatment that exists today, and also the important biological mechanisms